INTRODUCTION AND OBJECTIVES: Specific microbial signatures exist in the body to regulate external pathogens. While prior work has focused on the role of the adult genitourinary microbiome in urinary tract health, little research investigates the normal pediatric perineal microbiome and aberrations related to urinary tract infections (UTIs). We strove to define the genitourinary microbiome in the normal developing prepubertal female child and compared this to a small cohort of children with recurrent UTIs.
METHODS: After IRB approval, we consented healthy females at pediatric well-child visits to participate. Children were divided into 4 groups of significant developmental milestones: 1) 0-3 week old newborns; 2) 5-9 month old infants transitioning to solid foods; 3) 3-5 year old toddlers undergoing toilet training; and 4) 9-12 year old premenstrual girls. We also enrolled girls from the urology clinic with a history of UTIs (>50,000 colony forming units) who have been off antibiotics >1 month. Four swabs were taken on each patient: 1) genitourinary (urethral/vaginal introitus); 2) perirectal; 3) periauricular; 4) oral. Next generation 16S rRNA sequencing was performed to identify age and location of specific microbial signatures as well as a signature associated with recurrent UTIs.
RESULTS: A total of 40 patients were recruited: a) 13 newborns; b) 6 infants; c) 13 toddlers; d) 6 premenstrual girls; and e) 2 recurrent UTIs. Children with recurrent UTI were 15 months and 2 years old. There was a clear evolution of the perirectal and genitourinary microbiomes with age, showing divergence at 5-9 months of age. The newborn group had the tightest clustering of bacteria between perirectal and genitourinary microbiomes. Those with recurrent UTI fall outside of any age group clustering let alone their specific age group (Figure 1) . CONCLUSIONS: We are the first to describe the normal prepubertal microbiome. There is a clear divergence and personalization of perirectal and genitourinary microbiomes as early as 5-9 months of age. Likely the tight clustering of newborn perirectal and genitourinary microbiome is a result of the maternal genitourinary microbiome. Children with recurrent UTIs have a dysbiosis of their perineal microbiome compared to children without. This could represent a target of UTI prevention and/or treatment. 
PD12-04 LEUKOTRIENE B4 SIGNALING ACTIVATES INNATE UROTHELIAL DEFENSES AND PROTECTS THE BLADDER AND KIDNEYS AGAINST UROPATHOGENIC E. COLI (UPEC)
Yan Liu, Ellen Shapiro, Herbert Lepor, Xue-Ru Wu*, New York, NY INTRODUCTION AND OBJECTIVES: Leukotriene B4 (LTB4), a dihydroxy fatty acid derived from arachidonic acid, acts as a chemoattractant in non-urothelial tissues and plays a role in innate host defenses. However, virtually nothing is known about the role or, the lack thereof, of LTB4 in the urinary tract, which is the focus of the present study.
METHODS: Adult wild-type female mice (7-9 weeks) were inoculated via the transurethral route with type 1 piliated cystitis strain UTI89 or pyelonephritis strain CFT073 (10 7 cfu in 20 ml PBS). Urothelial production and urinary secretion of LTB4 was measured by ELISA, and its localization determined by confocal immunofluorescence microscopy. The effects of LTB4 deficiency on UPEC infections were examined by administering the wild-type mice with zileuton, an inhibitor of LTB4 production and by using knockout mice lacking arachidonate 5-lipoxygenase (ALOX5), a key enzyme in LTB4 biosynthesis. The resultant neutrophil infiltration, intracellular bacterial community (IBC) formation and clearance, neutrophil myeloperoxidase (MPO) activity, bacterial colony forming units were assessed under specific conditions and controls.
RESULTS: In the wild-type mice, both UPEC strains UTI89 and CFT073 triggered an 8-fold increase of LTB4 in urothelium over PBS controls 2 hours after inoculation. The urothelial level of LTB4 continued to rise, peaking at 12 hours and subsiding considerably at 24 hours, the two time points coinciding with the accumulation and clearance of IBC, respectively. Urine levels of LTB4 lagged slightly behind that of urothelium, probably reflecting time required for protein secretion. Inhibition of LTB4 by zileuton included in the UPEC inocula e266 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 significantly reduced MPO activity and neutrophil infiltration in the urothelium. In ALOX5 knockout mice, UTI89 and CFT073 inoculation caused four times more IBC than in wild-type mice. Consistent with this, neutrophils were extremely sparse in ALOX5 mice in comparison to the wild-type controls. Additionally, CFT073 were recovered in large numbers from the kidneys of ALOX5 knockout mice, but not from those of wild-type mice. CONCLUSIONS: Our study provides the first experimental evidence indicating that LTB4 signaling initially in the urothelium and later through the neutrophils plays a crucial role in eliciting innate urothelial defenses and in clearing UPECs from the lower and upper urinary tract. Deficiency in LTB4 signaling may contribute significantly to the increased susceptibility of the urinary system to uropathogenic E. colicaused infections.
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PD12-05 BIG POTASSIUM CHANNEL (BK) ACTIVITY IN FEMALE MOUSE BLADDER UMBRELLA CELLS IS ENHANCED BY BACTERIAL LIPOPOLYSACCHARIDE: AN ACUTE HOST RESPONSE IN URINARY TRACT INFECTION (UTI) PATHOGENESIS
Ming Lu*, New Haven, CT; Jian-ri Li, Taichung, Taiwan; Yan Li, Shanghai, China, People's Republic of; Shan Yu, Toby Chai, New Haven, CT
INTRODUCTION AND OBJECTIVES: Urothelial cells grown as a monolayer cannot recapitulate the differential function of urothelial cells (e.g. apical, intermediate, basal urothelial cells). Lipopolysaccharide (LPS)
has been used as a surrogate for E. coli in study of host response to urinary tract infections. We isolated basal membrane of apical urothelial cells from urothelial tissue for patch clamp studies. We measured potassium channel activities in the apical cell and how the large conductance potassium channel activity changed when the urothelium was exposed to LPS.
METHODS: Female C57BL/6 mice 8 to 12 weeks of age were used. Pure urothelium was dissected out using our published technique. Urothelium was placed luminal side down and umbrella cells were exposed after removing basal and intermediate cells with a glass micropipette (Fig. 1) . Both inside-out and cell attached configurations were used. Urothelium was exposed to 40 mg/ml of LPS for 30 minutes. Blockers of BK (paxilline, iberiotoxin), LPS (polymyxin B), protein kinase A (H89) were also used. RT-PCR was performed to assess expression of BK and LPS-receptors (TLR4, CD14, and MD-2).
RESULTS: Two K conductances were found, 28.3AE1pS and 200.6AE4pS. The 200pS channel was sensitive to intracellular calcium, voltage and blocked with iberiotoxin and paxilline. RT-PCR confirmed presence of BK in urothelium. This suggested that the 200pS channel was the BK channel. LPS significantly increased BK channel activity of NPo from 0.50AE0.13 to 1.62AE0.31 (p<0.001) (Fig. 2) ; this effect was abrogated by polymyxin B (Fig. 2) and H89. TLR4, CD14 and MD-2 mRNAs were expressed only in the urothelium and not lamina propria or detrusor smooth muscle.
CONCLUSIONS: To our knowledge, this is the first time basal membranes of umbrella cells have been patch clamped. LPS significantly increased BK channel activity. This change in apical membrane activity represents an early host urothelial cell response to UTI. While we did not study the downstream results of increased BK activity, it is likely that this would have shown increased urothelial cytokine release. This BK-dependent cytokine release mechanism has been described in macrophages. The NLRP3 inflammasome has gained recognition for its role in mediating inflammation through its activation of pro-inflammatory cytokines like IL-1b. It has been implicated in diabetic sequelae such as nephropathy, retinopathy, neuropathy, and vasculopathy, and in sterile cystopathy such as hemorrhagic cystitis and bladder outlet obstruction. We hypothesize that the NLRP3 inflammasome is activated in the inflammatory response in diabetic bladder dysfunction (DBD), the most common of all diabetic complications.
METHODS: Ins2 (Akita) diabetic mice and age-matched controls underwent 4hr voiding assays to determine development of early DBD, defined as increased frequency and smaller voided volumes. Inflammation and fibrosis were compared through bladder weights, Evans Blue assay, Masson 0 s trichrome stain, and H&E stain. Active caspase-1, a functional moiety of activated inflammasome, was targeted intracellularly by a fluorescent caspase inhibitor and measured through flow cytometry. Paired geometric mean fluorescence intensity was compared via paired T-test, and all other univariate analysis was performed with ANOVA. Significance was defined as p<.05.
RESULTS: Diabetic mice demonstrated DBD as early as week 11 with increased frequency of voids (p<.01), increased total voided volume (p<.05), and decreased volume per void (p<.05), compared to wild type mice. Inflammasome activation was evident as witnessed by increased active caspase-1 in diabetic mice (Figure 1 ). Diabetic mice also had increased Evans blue extravasation, indicating increased capillary permeability, an early sign of inflammation. Furthermore, diabetic bladders demonstrated hypertrophy compared to wild type bladders (20.6 vs 18.9mg; p¼0.2); however, there was no increase in collagen deposition or histological changes on H&E staining.
CONCLUSIONS: Inflammasomes are activated early in the development of diabetic bladder dysfunction and may contribute to the onset of voiding dysfunction.
